Nearly 200 women wrongly treated for recurrent UTIs in Queensland pharmacy pilot: new report  Â
The 'deviation from protocol' was not evident in an earlier evaluation.
An updated evaluation of Queensland’s pharmacy UTI prescribing pilot suggests dozens of patients were wrongly treated for recurrent infections.
The pilot, which ran from June 2020 to September 2022, involved hundreds of pharmacists diagnosing uncomplicated UTIs for a $19.95 consultation fee and then dispensing trimethoprim, nitrofurantoin or cefalexin as private scripts as indicated.
Patients were deemed ineligible for pharmacist treatment if they had certain risk factors, such as vaginal symptoms, a blood disorder or a self-reported history of recurrent UTIs.
This was defined in the protocol as two or more UTIs within six months, or three or more UTIs within 12 months.
